Castle Biosciences Inc
CSTL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001447362
In the last 90 days, Castle Biosciences Inc insiders filed 0 open-market purchases and 20 sales; 176 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Castle Biosciences Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 146 | 157 | +11 |
| Shares | 22.6M | 21.9M | −701.8K (−3.1%) |
| Value | $495.0M | $569.8M | +$74.8M (+15.1%) |
New holders (24)
Institutions that held Castle Biosciences Inc at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (13)
Institutions that held Castle Biosciences Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Sumitomo Mitsui Trust Holdings, Inc. | 443,882 | $9.74M |
| Nikko Asset Management Americas, Inc. | 443,882 | $9.57M |
| Stonepine Capital Management, LLC | 295,372 | $6.48M |
| Stanley-Laman Group, Ltd. | 43,875 | $963.0K |
| Cinctive Capital Management LP | 40,000 | $878.0K |
| Twinbeech Capital LP | 32,866 | $721.0K |
| Rice Hall James & Associates, LLC | 26,750 | $587.0K |
| Qube Research & Technologies Ltd | 18,792 | $412.0K |
| Marshall Wace, LLP | 10,400 | $228.0K |
| First Bank & Trust | 7,818 | $172.0K |
| Captrust Financial Advisors | 497 | $11.0K |
| Prospera Financial Services Inc | 125 | $3.00K |
| Tradewinds Capital Management, LLC | 5 | $0 |